New research about to get underway at the University of Virginia could help make life easier for people with Type One Diabetes- by possibly developing a fully automated insulin pump.

Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.

The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

TNDM enters a multi-year research collaboration with the UVA Center for Diabetes Technology for the development of AID systems.

A new study published in the NEJM Evidence journal showed that automated insulin delivery reduced hypoglycemia in older ...

UVA Center for Diabetes has signed an agreement to advance research on fully automated insulin delivery systems.

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its ...

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.

The convergence of advanced technologies and advancements in drug delivery is reshaping diabetes care. Digital therapeutics ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering.  Read more here.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the ...